Literature DB >> 2960986

Increased adult behavioral 'despair' in rats neonatally exposed to desipramine or zimeldine: an animal model of depression?

L A Hilakivi1, I Hilakivi.   

Abstract

Occurrence of depressive behavior at mature age was studied in rats exposed neonatally to antidepressant drugs. Early antidepressant treatments have been shown to increase voluntary alcohol consumption and the percentage of rapid-eye-movement (REM) sleep relative to total sleep time in adult rats as well as to cause long-lasting reduction in the concentrations of monoamines in the forebrain. In the present study rats were daily given either 5 mg/kg desipramine or 25 mg/kg zimeldine from the 7th to the 18th postnatal days. When they were 2 months and 5 months of age behavioral 'despair' was studied by using a modified version of Porsolt's swim-test. At both ages the desipramine-treated and zimeldine-treated rats expressed lengthened immobility times in the water pail. The findings indicate that neonatal exposure of rats to desipramine or zimeldine induces behavioral 'despair' at mature age. Thus, early exposure of rats to antidepressants causes long-lasting behavioral disorders, and, moreover, may be used to devise an animal model of subsequent depression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960986     DOI: 10.1016/0091-3057(87)90454-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  Behavioral despair in mice after prenatal stress.

Authors:  S J Alonso; C Damas; E Navarro
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

2.  Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.

Authors:  Maxine Norcross; Poonam Mathur; Mathur Poonam; Abigail J Enoch; Rose-Marie Karlsson; Jonathan L Brigman; Heather A Cameron; Judith Harvey-White; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

3.  Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Authors:  V Bhagya; B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2010-11-04       Impact factor: 4.530

Review 4.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

5.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

6.  Early postnatal treatment with propranolol affects development of brain amines and behavior.

Authors:  L A Hilakivi; T Taira; I Hilakivi; E MacDonald; L Tuomisto; K Hellevuo
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Effects of monoamine uptake inhibitors given early postnatally on monoamines in the brain stem, caudate/putamen and cortex, and on dopamine D1 and D2 receptors in the caudate/putamen.

Authors:  I Hilakivi; L Ahtee; J O Rinne; T Taira; L M Attila; P Marjamaki
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Authors:  Ouissame Mnie-Filali; Céline Faure; Laura Lambás-Señas; Mostafa El Mansari; Hassina Belblidia; Elise Gondard; Adeline Etiévant; Hélène Scarna; Anne Didier; Anne Berod; Pierre Blier; Nasser Haddjeri
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

9.  Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.

Authors:  Dorota Maciag; Lashondra Williams; David Coppinger; Ian A Paul
Journal:  Eur J Pharmacol       Date:  2006-02-14       Impact factor: 4.432

Review 10.  Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease.

Authors:  Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2008-03-26       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.